Switch to side-by-side view

--- a
+++ b/clusters/9knumclustersv2/clust_1236.txt
@@ -0,0 +1,51 @@
+Histologically confirmed or cytologically confirmed diagnosis of stage IV NSCLC
+Have previously untreated, histologically confirmed NSCLC and histologically confirmed Stage IIB or IIIA NSCLC.
+Patient must have histologically or cytologically confirmed metastatic or recurrent NSCLC which is progressing.
+Histologically or cytologically confirmed diagnosis of NSCLC that carries an ALK rearrangement
+Histologically or cytologically confirmed non-squamous NSCLC
+Histologically confirmed non-squamous NSCLC, with incurable advanced or metastatic disease
+Have a histologically confirmed diagnosis of NSCLC
+Patients with histologically or cytologically confirmed stage IV NSCLC not amendable to curative surgery or radiation
+Has histologically or cytologically documented adenocarcinoma NSCLC.
+Histologically cytologically confirmed NSCLC
+Histologically or cytologically confirmed diagnosis of NSCLC that is:
+Histologically confirmed diagnosis of NSCLC
+Have histologically- or cytologically-confirmed diagnosis of Stage IV NSCLC and meet the corresponding requirements for the cohort of the study they will enroll into;
+Cytologically or histologically confirmed non squamous NSCLC Stage IV (including pleural effusion).
+Histologically or cytologically confirmed diagnosis of Stage IV non-squamous NSCLC.
+A histologically or cytologically confirmed diagnosis of stage IV NSCLC
+Subjects with histologically or cytologically confirmed NSCLC:
+Has a histologically-confirmed or cytologically confirmed diagnosis of stage IV nonsquamous NSCLC.
+Histologically or cytologically documented diagnosis of NSCLC
+Histologically or cytologically confirmed Stage IIIB-IVB NSCLC
+Have histologically or cytologically confirmed squamous NSCLC.
+Histologically or cytologically confirmed, treatment-nave Stage IV squamous NSCLC
+Histologically or cytologically confirmed diagnosis of NSCLC with single activating EGFR mutations (LR or ExonDel).
+Subject must have cytologically or histologically confirmed advanced or metastatic non-squamous NSCLC and are current or former smokers.
+Subjects with histologically or cytologically documented NSCLC.
+Subject must have cytologically or histologically confirmed squamous NSCLC.
+Histologically or cytologically documented NSCLC
+Histologically or cytologically confirmed metastatic or recurrent NSCLC; primary or metastatic site may be used for histology
+Histologically-  or cytologically-confirmed, treatment naive (or status post treatment regimens of tyrosine kinase inhibitor and/or immunotherapy) stage IV non-squamous, NSCLC
+histologically or cytologically proven diagnosis of malignancy other than NSCLC
+Histologically or cytologically confirmed NSCLC
+Histologically or cytologically confirmed stage IIIB or IV NSCLC with non-squamous histology
+Histologically or cytologically confirmed squamous or non-squamous NSCLC
+Must have histologically or cytologically confirmed non-squamous NSCLC.
+Histologically confirmed squamous advanced NSCLC (Stage IV).
+Has a histologically and/or cytologically confirmed diagnosis of NSCLC (squamous or nonsquamous).
+Stage IV, histologically or cytologically confirmed NSCLC; confirmation may be obtained with the first protocol-specified tumor biopsy
+Must have cytologically or histologically confirmed NSCLC with either:
+Histologically or cytologically confirmed, newly diagnosed non-squamous NSCLC
+Have a histologically or cytologically confirmed diagnosis of stage IV NSCLC.
+Histologically or cytologically confirmed Stage IV non-squamous NSCLC
+Histologically or cytologically confirmed Stage IV squamous NSCLC
+Diagnosis of NSCLC, histologically or cytologically confirmed
+Histologically or cytologically confirmed advanced/metastatic SCLC or NSCLC
+Histologically or cytologically confirmed unresectable NSCLC
+Histologically or cytologically confirmed non-squamous NSCLC
+The participant has histologically or cytologically confirmed, nonsquamous (adenocarcinoma/large cell or other) NSCLC.
+Patients with stage IV or recurrent/metastatic histologically or cytologically confirmed non-squamous NSCLC
+Histologically or cytologically confirmed, Stage IV non-squamous or squamous NSCLC
+Has histologically or cytologically documented adenocarcinoma NSCLC
+Histologically or cytologically confirmed metastatic NSCLC including recurrent disease